5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study
Frontiers in Psychiatry November 23, 2023 Anya Ragnhildstveit, Ryan Khan, Paul Seli et al. 17 citations
Psychedelic therapy is, arguably, the next frontier in psychiatry. It offers a radical alternative to longstanding, mainstays of treatment, while exciting a paradigm shift in translational science and drug discovery. There is particular interest in 5-methoxy- N,N -dimethyltryptamine (5-MeO-DMT)—a serotonergic psychedelic—as a novel, fast-acting therapeutic. Yet, few studies have directly...